Podcast Episodes
Back to Search
Ep. 98 - Inside Precision Oncology’s Next Chapter with Fore’s Bill Hinshaw
Season 4 Episode 98
When Bill Hinshaw looks back across the arc of his career — from his early days helping to commercialize Gleevec to his present role leading Fore Bio…
8 months, 4 weeks ago
Popular Episode - Reimagining FDA: Steve Usdin on Designing the Drug Regulator of the Future
Season 4
This is a previously recorded episode of The BioCentury Show from September 5, 2025. Subscribe to this channel to listen to each new episode. Visit T…
9 months, 1 week ago
Ep. 97 – From NIH to Industry: Zerhouni Warns Policy & Rhetoric Threaten U.S. Science
Season 4 Episode 97
Elias Zerhouni personifies the American dream. He arrived in the U.S. from Algeria as a young man with a couple of hundred dollars in his pocket. Tal…
9 months, 3 weeks ago
Ep. 96 – From Pharma Partnering to Biotech CEO: Sophie Kornowski on Boston Pharma’s Playbook
Season 4 Episode 96
It took Sophie Kornowski under four years as CEO of Boston Pharma to bring it from a pipeline full of in-licensed assets to an acquisition by GSK for…
10 months ago
Ep. 95 - Kymera CEO Nello Mainolfi: Matching Degrader Chemistry to the Problem
Season 4 Episode 95
Kymera Therapeutics has a clear mission: to transform immunology with targeted protein degraders that enable “oral drugs with biologics-like activity…
10 months, 2 weeks ago
Ep. 94 - Frazier's James Li on China’s Rapidly Evolving Biotech Deal Landscape
Season 4 Episode 94
The frenzy among Western companies to access China’s biotechnology innovation is remaking the landscape for cross-border dealmaking, with assets beco…
11 months ago
Ep. 93 – BIO’s Fritz Bittenbender on Trump 2.0, MFN Threats & Pharma’s Concessions
Season 4 Episode 93
President Donald Trump’s demands for “most favored nation” drug pricing presents the biopharma industry with an immense public policy challenge. Drug…
11 months, 2 weeks ago
Ep. 92 - Reimagining FDA: Steve Usdin on Designing the Drug Regulator of the Future
Season 4 Episode 92
If you could redesign FDA from the ground up, what would it look like? That’s the fundamental question underlying the 2025 BioCentury Back to School …
11 months, 4 weeks ago
Ep. 91 – Annalisa Jenkins: How MHRA’s Reset Could Revive U.K. Biotech
Season 4 Episode 91
A new head at MHRA, a streamlined government life sciences strategy, and a more sophisticated innovation ecosystem have Annalisa Jenkins optimistic a…
1 year ago
Popular Episode - Vertex’s Winning Formula: Altshuler on Choosing the Next Breakthroughs
Season 4
This is a previously recorded episode of The BioCentury Show from March 19, 2025. Subscribe to this channel to listen to each new episode. Visit TheB…
1 year ago